Switch theme
Sign up to access all valuation multiples
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
1978
193
Last FY Revenue $40.9M
Last FY EBITDA $16.4M
$103M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Utah Medical achieved revenue of $40.9M and an EBITDA of $16.4M.
Utah Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Utah Medical valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $40.9M | XXX | XXX | XXX |
| Gross Profit | XXX | $24.1M | XXX | XXX | XXX |
| Gross Margin | XXX | 59% | XXX | XXX | XXX |
| EBITDA | XXX | $16.4M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 40% | XXX | XXX | XXX |
| EBIT | XXX | $13.6M | XXX | XXX | XXX |
| EBIT Margin | XXX | 33% | XXX | XXX | XXX |
| Net Profit | XXX | $13.9M | XXX | XXX | XXX |
| Net Margin | XXX | 34% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 2, 2025, Utah Medical's stock price is $57.
Utah Medical has current market cap of $186M, and EV of $103M.
See Utah Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $103M | $186M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 2, 2025, Utah Medical has market cap of $186M and EV of $103M.
Utah Medical's trades at 2.5x EV/Revenue multiple, and 6.3x EV/EBITDA.
Equity research analysts estimate Utah Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Utah Medical's P/E ratio is not available.
See valuation multiples for Utah Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $186M | XXX | $186M | XXX | XXX | XXX |
| EV (current) | $103M | XXX | $103M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 2.5x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 6.3x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 7.6x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 13.4x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 7.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialUtah Medical's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Utah Medical's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Utah Medical's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Utah Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 40% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 5% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 26% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Utah Medical acquired XXX companies to date.
Last acquisition by Utah Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Utah Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Utah Medical founded? | Utah Medical was founded in 1978. |
| Where is Utah Medical headquartered? | Utah Medical is headquartered in United States of America. |
| How many employees does Utah Medical have? | As of today, Utah Medical has 193 employees. |
| Who is the CEO of Utah Medical? | Utah Medical's CEO is Mr. Kevin L. Cornwell. |
| Is Utah Medical publicy listed? | Yes, Utah Medical is a public company listed on NAS. |
| What is the stock symbol of Utah Medical? | Utah Medical trades under UTMD ticker. |
| When did Utah Medical go public? | Utah Medical went public in 1982. |
| Who are competitors of Utah Medical? | Similar companies to Utah Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Utah Medical? | Utah Medical's current market cap is $186M |
| Is Utah Medical profitable? | Yes, Utah Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
